Formulation of pH-Responsive PEGylated Nanoparticles with High Drug Loading Capacity and Programmable Drug Release for Enhanced Antibacterial Activity
February 2022
in “
Bioactive Materials
”
Studysummary This study reported the development of pH-responsive nanoparticles that effectively deliver vancomycin in a controlled manner, demonstrated enhanced antibacterial activity, and showed promise for clinical applications by targeting bacterial infection sites with programmable drug release.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on sciencedirect.com →